About
FAQ
Reports
Contact Us
Works
Groups
People
Publications
Publishers
In Press
Advanced
Future Medicine
SHERPA: White
People
Stein
Groups
Adult Leukemia
(1)
Center for Hematologic Malignancies
(1)
Department of Medicine
(1)
Hematologic Malignancies, Division of
(1)
Search Within
"Eytan Stein"
Formats
Journal Article (1)
Groups
Adult Leukemia (1)
Center for Hematologic Malignancies (1)
Department of Medicine (1)
Hematologic Malignancies, Division of (1)
People
Eytan Stein (1)
Years
2018 (1)
Publications
Future Oncology (1)
Results (1)
Export to EndNote / Excel
Show:
10
20
50
100
250
500
1000
2000
Sort By:
Author
Title
Year
Relevance
Created
Order:
Ascending
Descending
Style:
Nature
NLM
NIH-PMCID
Citation style sort is year ascending, and then by author or title. Author ascending is default.
Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia
Journal Article
Stein, E. M.
Future Oncology
(2018)
Fulltext@MSK
|
Save
Future Medicine – authorized name for:
Future Medicine
Future Medicine Ltd
Future Medicine Ltd.
Future Medicine